Michael Rivers, MD, Sr. Medical Director of Ophthalmology, ModMed
The headline-grabbing emergence of generative AI platforms, such as ChatGPT, BARD and BingGPT, has forced leaders across all verticals to ask, “What can we optimize with…
Continue Reading
What You Should Know:
Smart Eye, a developer of Driver Monitoring System (DMS) technology for the automotive industry adds vital signs detection that analyzes multiple physiological signals to remotely monitor heart and respiration rates, enabling…
Continue Reading
What You Should Know:
Rimidi, a clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives, is announcing enhancements to its diabetes management platform, including the addition of Glycemic Risk…
Continue Reading
by Healthcare M&A 06/23/2023 Leave a Comment
What You Should Know:
Quest Diagnostics announced that it has completed its $450M acquisition of Haystack Oncology.Haystack Oncology has developed a highly sensitive minimal-residual disease (MRD) testing technology, based…
Continue Reading
SpassMed scores US FDA 510(k) for AI sepsis detection softwareSouth Korean medical AI company SpassMed has received the United States Food and Drug Administration’s 510(k) clearance for its AI-powered sepsis detection software.
The AI solution…
Multinational digital health firm Babylon announced it has accepted a take-private proposal from AlbaCore Capital LLP on behalf of its affiliate MindMaze, which makes game-like rehabilitation tools for neurological conditions and injuries, which will…
Continue Reading
Amazon Web Services this week announced a new artificial intelligence initiative designed to help customers across numerous industries make better use of advancements in machine learning and automation, and scope high-value use cases based…
Continue Reading
Multinational digital health firm Babylon announced it has accepted a take-private proposal from AlbaCore Capital on behalf of its affiliate digital-neurotherapy company MindMaze, which will transition Babylon from a publicly-traded company to a private…
Continue Reading
Multinational digital health firm Babylon announced it has accepted a take-private proposal from AlbaCore Capital on behalf of its affiliate digital-neurotherapy company MindMaze, which will transition Babylon from a publicly-traded company to a private…
Continue Reading
The healthcare industry faced several headwinds in the last year, such as higher interest rates, more antitrust regulatory review concerns, higher valuations and recession worries. But despite these headwinds, health services deals “remained resilient”…
Continue Reading
